Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward

Chimeric antigen receptor T-cell (CAR-T) therapy has been successful in creating extraordinary clinical outcomes in the treatment of hematologic malignancies including relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL). With several FDA approvals, CAR-T therapy is recognized as...

Descripción completa

Detalles Bibliográficos
Autores principales: Safarzadeh Kozani, Pouya, Safarzadeh Kozani, Pooria, Rahbarizadeh, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581403/
https://www.ncbi.nlm.nih.gov/pubmed/34777381
http://dx.doi.org/10.3389/fimmu.2021.765097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581403/
https://www.ncbi.nlm.nih.gov/pubmed/34777381
http://dx.doi.org/10.3389/fimmu.2021.765097

Ejemplares similares